Canlyniadau Chwilio - Nathalie Auger
- Dangos 1 - 20 canlyniadau o 37
- Ewch i'r Dudalen Nesaf
-
1
-
2
-
3
-
4
-
5
-
6
Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada gan Daniel T. Myran, Peter Tanuseputro, Nathalie Auger, Lauren Konikoff, Robert Talarico, Yaron Finkelstein
Cyhoeddwyd 2023Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer gan Emma Pailler, Nathalie Auger, Colin R. Lindsay, Philippe Vielh, A. Islas-Morris-Hernandez, Isabelle Borget, Maud Ngo‐Camus, David Planchard, Jean‐Charles Soria, B. Besse, F Farace
Cyhoeddwyd 2015Artigo -
15
Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer gan Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, Isabelle Borget, David Planchard, Mélissa Taylor, Fabrice André, Jean Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace
Cyhoeddwyd 2013Artigo -
16
IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy gan Charles Ferté, Yohann Loriot, Céline Clémenson, Frédéric Commo, Andrea Gombos, Jean‐Emmanuel Bibault, I. Fumagalli, Saad Hamama, Nathalie Auger, Benoît Lahon, Cyrus Chargari, Julien Caldéraro, Jean‐Charles Soria, Éric Deutsch
Cyhoeddwyd 2013Artigo -
17
Crizotinib-Resistant <i>ROS1</i> Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for <i>ROS1</i>- and <i>ALK</i>-Rearranged Lung Cancers gan Francesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, Linda Mahjoubi, Ludovic Lacroix, David Planchard, Benjamin Besse, Françoise Farace, Nathalie Auger, Jordi Remón, Jean–Yves Scoazec, Fabrice André, Jean‐Charles Soria, Luc Friboulet
Cyhoeddwyd 2016Artigo -
18
Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patie... gan Emma Pailler, Marianne Oulhen, Isabelle Borget, Jordi Remón, Kirsty Ross, Nathalie Auger, Fanny Billiot, Maud Ngo Camus, Frédéric Commo, Colin R. Lindsay, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace
Cyhoeddwyd 2017Artigo -
19
Establishment of Human Colon Cancer Cell Lines from Fresh Tumors versus Xenografts: Comparison of Success Rate and Cell Line Features gan Virginie Dangles-Marie, Marc Pocard, Sophie Richon, Louis‐Bastien Weiswald, Franck Assayag, Patrick Saulnier, Jean‐Gabriel Judde, Jean-Louis Janneau, Nathalie Auger, Pierre Validire, Bernard Dutrillaux, Françoise Praz, Dominique Bellet, Marie‐France Poupon
Cyhoeddwyd 2007Artigo -
20
Cohort Profile: The Nicotine Dependence in Teens (NDIT) Study gan Jennifer O’Loughlin, Erika N. Dugas, Jennifer Brunet, Joseph R. DiFranza, James C. Engert, André Gervais, Katherine Gray-Donald, Igor Karp, Nancy Low, Catherine Sabiston, Marie-Pierre Sylvestre, Rachel F. Tyndale, Nathalie Auger, Nathalie Auger, Belanger Mathieu, Barnett Tracie, Michael Chaiton, Meghan J. Chenoweth, Evelyn Constantin, Gisèle Contreras, Lisa Kakinami, Aurélie Labbe, Katerina Maximova, Elizabeth McMillan, Erin K. O’Loughlin, Roman Pabayo, Marie‐Hélène Roy‐Gagnon, Michèle Tremblay, Robert J. Wellman, Andraea Van Hulst, Gilles Paradis
Cyhoeddwyd 2014Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Biology
Internal medicine
Genetics
Cancer research
Cancer
Gene
Oncology
Pathology
Pediatrics
Environmental health
Chromosome
Cohort
DNA
Lung cancer
Population
Cell culture
Cohort study
Confidence interval
Crizotinib
Malignant pleural effusion
Psychiatry
ALK inhibitor
Biochemistry
Hazard ratio
Leukemia
Mutation
Pregnancy
Proportional hazards model
Sociology